Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin

Cancer Science

Volumn 98, Issue 3, 2007, Pages 350-356

  Kawada, Manabu ^a   Inoue, Hiroyuki ^a   Arakawa, Masayuki ^a   Takamoto, Kozo ^a   Masuda, Tohru ^a   Ikeda, Daishiro ^a  

^a Numazu Bio Medical Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANGIOGENIN; COMPLEMENTARY DNA; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RIBONUCLEASE, PANCREATIC; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846676270     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00407.x     Document Type: Article

References (40)

1. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowely DR. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 2002; 62: 3298-307.
2. Kawada M, Inoue H, Usami I et al. Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance. Cancer Lett 2006; 242: 46-52.
3. Patel EJ, Pantuck AJ, Zisman A et al. CL-1-GFP: An androgen independent metastatic tumor model for prostate cancer. J Urol 2000; 164: 1420-5.
4. Chen CD, Welsbie DS, Tran C et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10: 33-9.
5. Fett JW, Strydom DJ, Lobb RR et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24: 5480-6.
6. Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 1986; 25: 3527-32.
7. Hallaha TW, Shapiro R, Vallee BL. Dual site model for the organogenic activity of angiogenin. Proc Natl Acad Sci USA 1991; 88: 2222-6.
8. Bicknell R, Vallee BL. Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2. Proc Natl Acad Sci USA 1989; 86: 1573-7.
9. Badet J, Soncin F, Guitton J-D, Lamare O, Cartwright T, Barritault D. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci USA 1989; 86: 8427-31.
10. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005; 24: 445-56.
11. Hu GF, Strydom DJ, Fett JW, Riordan JF, Vallee BL. Actin is a binding protein for angiogenin. Proc Natl Acad Sci USA 1993; 90: 1217-21.
12. Soncin F, Shapiro R, Fett JW. A cell-surface proteoglycan mediates human adenocarcinoma HT-29 cell adhesion to human angiogenin. J Biol Chem 1994; 269: 8999-9005.
13. Tsuji T, Sun Y, Kishimoto K et al. Angiogenin is transloctated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 2005; 65: 1352-60.
14. Yoshioka N, Wang L, Kishimoto K, Tsuji T, Hu GF. A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA 2006; 103: 14519-24.
15. Rybak SM, Fett JW, Yao Q-Z, Vallee BL. Angiogenin mRNA in human tumor and normal cells. Biochem Biophys Res Commun 1987; 146: 1240-8.
16. Li D, Bell J, Brown A, Berry CL. The observation of anigogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 1994; 172: 171-5.
17. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 1996; 56: 2703-6.
18. Montero S, Guzman C, Cortes-Funes H, Colomer R. Angiogenin expression and prognosis in primary breast carcinoma. Clin Cancer Res 1998; 4: 2161-8.
19. Olson KA, Byers HR, Key ME, Fett JW. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int J Cancer 2002; 98: 923-9.
20. Hartmann A, Kunz M, Kostlin S et al. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 1999; 59: 1578-83.
21. Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S, Kamidono S. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to progression and recurrence. Cancer 1999; 86: 316-24.
22. Shimoyama S, Yamasaki K, Kawahara M, Kaminishi M. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin Cancer Res 1999; 5: 1125-30.
23. Shimoyama S, Kaminishi M. Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol 2000; 126: 468-74.
24. Bodner-Adler B, Hefler L, Bodner K et al. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN). Anticancer Res 2001; 21: 809-12.
25. Hisai H, Kato J, Kobune M et al. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res 2003; 9: 4852-9.
26. Barton DPJ, Cai A, Wendt K, Young M, Ganero A, DeCesare S. Angiogenin protein expression in advanced epithelial ovarian cancer. Clin Cancer Res 1997; 3: 1579-86.
27. Wechsel HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E. Renal cell carcinoma: Relevance of angiogenetic factors. Anticancer Res 1999; 19: 1537-40.
28. Zhao H, Grossman H, Delclos G et al. Increased plasma levels of angiogenin and the risk of bladder carcinoma. Cancer 2005; 104: 30-5.
29. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenin in malignant melanoma patients with tumor progression and survival. J Clin Oncol 2001; 19: 1207-25.
30. Fukazawa H, Mizuno S, Uehara Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal Biochem 1995; 228: 83-90.
31. Yang D, Howard OMZ, Chen Q, Oppenheim JJ. Cutting edge: Immature dendritic cells generated from monocytes in the presence of TGF-β1 express functional C-C chemokine receptor 6. J Immunol 1999; 163: 1734-41.
32. Balbay MD, Pettaway CA, Kuniyasu H et al. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Clin Cancer Res 1999; 5: 783-9.
33. Chen T, Wnag LH, Farrar WL. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res 2000; 60: 2132-5.
34. Matsuda T, Junicho A, Yamamoto T et al. Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells. Biochem Biophys Res Commun 2001; 283: 179-87.
35. Chen J, Gao Y, Liu J, Tian Y, Zhao J, Cui X. Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells. Int J Biochem Cell Biol 2005; 37: 1219-31.
36. Olson KA, French TC, Vallee BL, Fett JW. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res 1994; 54: 4576-9.
37. Kao RYT, Jenkins JL, Olson KA, Key ME, Fett JW, Shapiro R. A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity. Proc Natl Acad Sci USA 2002; 99: 10066-71.
38. Olson KA, Byers HR, Key ME, Fett JW. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin Cancer Res 2001; 7: 3598-605.
39. Gho YS, Yoon W-H, Chae C-B. Antiplasmin activity of a peptide that binds to the receptor-binding site of angiogenin. J Biol Chem 2002; 277: 9690-4.
40. Wang T, Yang M, Chen J, Watkins T, Xiuyun C. Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor. Anigogenesis 2005; 8: 73-81.